From your link:
"First, we expect that the decline seen over the last week (and especially based on the fact that it has accelerated over the last couple of days) is indicative of markets expecting Tenax to miss its target January release timeframe. The miss is resulting in a bit of a sell off, and impacting sentiment. Second, that – for us, at least – if the company misses its target by a few days or week or so, it’s not that big a deal. This trial has been a bit of a roller coaster, and that the topline report is set to hit press even near term is a positive.
So what are we looking for?
We are watching closely for any indication from the company that it is about to put out topline data. The first couple of days of next week are still open for the company to meet its January target, and if we do see numbers hit press, and – in turn – they are positive, we expect some sharp upside."
News 
Market Data 
Discover 
